Table of Contents

• 1.1 List of Tables 7
• 1.2 List of Figures 9

2 Introduction 10

• 2.1 Hematology Analyzers Overview 10

3 Products under Development 11

• 3.1 Hematology Analyzers - Pipeline Products by Stage of Development 11
• 3.2 Hematology Analyzers - Pipeline Products by Segment 12
• 3.3 Hematology Analyzers - Pipeline Products by Territory 13
• 3.4 Hematology Analyzers - Pipeline Products by Regulatory Path 14
• 3.5 Hematology Analyzers - Pipeline Products by Estimated Approval Date 15
• 3.6 Hematology Analyzers - Ongoing Clinical Trials 16

4 Hematology Analyzers - Pipeline Products under Development by Companies 17

• 4.1 Hematology Analyzers Companies - Pipeline Products by Stage of Development 17
• 4.2 Hematology Analyzers - Pipeline Products by Stage of Development 19

5 Hematology Analyzers Companies and Product Overview 20

• 5.1 Analyticon Biotechnologies AG Company Overview 20
  • 5.1.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 20
• 5.2 Antigon SA Company Overview 21
  • 5.2.1 Antigon SA Pipeline Products & Ongoing Clinical Trials Overview 21
• 5.3 Apollo Medical Devices LLC Company Overview 22
  • 5.3.1 Apollo Medical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview 22
• 5.4 Ativa Medical Inc Company Overview 23
  • 5.4.1 Ativa Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 23
• 5.5 Beckman Coulter Inc Company Overview 24
  • 5.5.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 24
• 5.6 Cell.Copedia GmbH Company Overview 26
  • 5.6.1 Cell.Copedia GmbH Pipeline Products & Ongoing Clinical Trials Overview 26
• 5.7 Cellmic LLC Company Overview 27
  • 5.7.1 Cellmic LLC Pipeline Products & Ongoing Clinical Trials Overview 27
• 5.8 Daxor Corp Company Overview 28
  • 5.8.1 Daxor Corp Pipeline Products & Ongoing Clinical Trials Overview 28
• 5.9 Diatron Medical Instruments Limited Company Overview 29
  • 5.9.1 Diatron Medical Instruments Limited Pipeline Products & Ongoing Clinical Trials Overview 29
• 5.10 EasyDx Inc Company Overview 31
  • 5.10.1 EasyDx Inc Pipeline Products & Ongoing Clinical Trials Overview 31
• 5.11 EKF Diagnostics Holdings Plc Company Overview 32
  • 5.11.1 EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 32
• 5.12 Entegrion Inc Company Overview 35
  • 5.12.1 Entegrion Inc Pipeline Products & Ongoing Clinical Trials Overview 35
• 5.13 HemoPalm Corp Company Overview 38
  • 5.13.1 HemoPalm Corp Pipeline Products & Ongoing Clinical Trials Overview 38
• 5.14 iFirst Medical Technologies LLC Company Overview 40
  • 5.14.1 iFirst Medical Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 40
• 5.15 Indian Institute of Science Company Overview 41
  • 5.15.1 Indian Institute of Science Pipeline Products & Ongoing Clinical Trials Overview 41
• 5.16 Ionu Biosystems Company Overview 42
  • 5.16.1 Ionu Biosystems Pipeline Products & Ongoing Clinical Trials Overview 42
• 5.17 IRIS International Inc Company Overview 43
  • 5.17.1 IRIS International Inc Pipeline Products & Ongoing Clinical Trials Overview 43
• 5.18 Nova Biomedical Corp Company Overview 44
  • 5.18.1 Nova Biomedical Corp Pipeline Products & Ongoing Clinical Trials Overview 44
• 5.19 Quotient Ltd Company Overview 48
  • 5.19.1 Quotient Ltd Pipeline Products & Ongoing Clinical Trials Overview 48
• 5.20 Redbud Labs Inc Company Overview 52
  • 5.20.1 Redbud Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 52
• 5.21 Rutgers University Company Overview 54
  • 5.21.1 Rutgers University Pipeline Products & Ongoing Clinical Trials Overview 54
• 5.22 Siemens Healthcare Diagnostics Inc Company Overview 55
  • 5.22.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 55
• 5.23 Sight Diagnostics Ltd Company Overview 56
  • 5.23.1 Sight Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 56
• 5.24 SigTuple Technologies Pvt Ltd Company Overview 59
  • 5.24.1 SigTuple Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 59
• 5.25 Sysmex Corp Company Overview 60
  • 5.25.1 Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview 60
• 5.26 University of British Columbia Company Overview 61
  • 5.26.1 University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview 61
• 5.27 ViroGates AS Company Overview 62
  • 5.27.1 ViroGates AS Pipeline Products & Ongoing Clinical Trials Overview 62

6 Hematology Analyzers- Recent Developments 63

• 6.1 Nov 04, 2019: Quotient reports second quarter fiscal 2020 financial results 63
• 6.2 Nov 01, 2019: Haemonetics reports 2nd quarter and 1st half fiscal 2020 results; raises fiscal 2020 adjusted operating margin and adjusted EPS guidance 65
• 6.3 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results 67
• 6.4 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results. 68
• 6.5 Oct 29, 2019: ELITech Group announces direct sales and customer support in Canada 69
• 6.6 Oct 23, 2019: CellaVision: Continued growth and acquisition of RAL Diagnostics 69
• 6.7 Oct 16, 2019: Abbott reports third-quarter 2019 results 71
• 6.8 Oct 16, 2019: Trinity Biotech announces results for Q3, 2019 74
• 6.9 Oct 15, 2019: Eurobio Scientific: Strong earnings growth for the first half of 2019 75
• 6.10 Oct 08, 2019: Instrumentation Laboratory awarded 2019 IMV ServiceTrak award for best Hemostasis System performance 76

7 Appendix 177

• 7.1 Methodology 177
• 7.2 About GlobalData 180
• 7.3 Contact Us 180

Hematology Analyzers - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Hematology Analyzers - Medical Devices Pipeline Assessment, 2019" provides an overview of Hematology Analyzers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hematology Analyzers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Hematology Analyzers under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Hematology Analyzers and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Hematology Analyzers under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date